These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5671348)

  • 1. Lag time before essentially constant urinary excretion rate is attained.
    Wagner JG; Northam JI
    J Pharm Sci; 1968 Jun; 57(6):994-9. PubMed ID: 5671348
    [No Abstract]   [Full Text] [Related]  

  • 2. Fallacy in concluding there are zero-order kinetics from blood level and urinary excretion data.
    Wagner JG
    J Pharm Sci; 1967 May; 56(5):586-94. PubMed ID: 6032770
    [No Abstract]   [Full Text] [Related]  

  • 3. The urinary elimination "time lag": determination of the mean residence time from drug accumulation in the urine during infusion.
    Siegel RA
    J Pharm Sci; 1986 Jun; 75(6):627-8. PubMed ID: 3735112
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics: interrelation of renal elimination rate constant of a drug and urinary flow rate.
    Fülgraff G
    Arzneimittelforschung; 1972 Jul; 22(7):1231. PubMed ID: 4678138
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Pharmacology; 1972; 8(1):102-17. PubMed ID: 4644642
    [No Abstract]   [Full Text] [Related]  

  • 6. Classical bioavailability methods: blood levels and urinary excretion.
    Dittert LW
    Psychopharmacol Bull; 1976 Oct; 12(4):54-5. PubMed ID: 972991
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties of the one-compartmental model with nonlinear elimination.
    Wang CY
    Arzneimittelforschung; 1977; 27(12):2368-71. PubMed ID: 580052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo loss of tritium from labeled drugs: determinations in urine and plasma.
    Lukas G; Redalieu E
    J Pharm Sci; 1976 Aug; 65(8):1261-2. PubMed ID: 824438
    [No Abstract]   [Full Text] [Related]  

  • 9. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.
    Riegelman S; Loo JC; Rowland M
    J Pharm Sci; 1968 Jan; 57(1):117-23. PubMed ID: 5652110
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid methods for bioavailability determination utilizing urinary excretion data.
    Niebergall PJ; Sugita ET; Schnaare RL
    J Pharm Sci; 1975 Oct; 64(10):1721-2. PubMed ID: 1185547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for estimating rate constants for absorption, metabolism, and elimination from urinary excretion data.
    Wagner JG
    J Pharm Sci; 1967 Apr; 56(4):489-94. PubMed ID: 6034546
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetics and compartmental analysis].
    Grégoire F
    J Pharm Belg; 1972; 26(3):355-70. PubMed ID: 5048358
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of data from drug urinary excretion.
    Martin BK
    Nature; 1967 Apr; 214(5085):247-9. PubMed ID: 6034239
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug urinary excretion data--some aspects concerning the interpretation.
    Martin BK
    Br J Pharmacol Chemother; 1967 Feb; 29(2):181-93. PubMed ID: 6032054
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of urinary pH on renal excretion of drugs.
    Madan PL
    JAMA; 1977 Jul; 238(3):210. PubMed ID: 17758
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of urinary excretion studies to dosage form evaluation.
    Baldridge JL
    Bull Parenter Drug Assoc; 1969; 23(1):40-7. PubMed ID: 5765720
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Pre-race drug testing.
    Maylin GA
    Cornell Vet; 1974 Jul; 64(3):325-34. PubMed ID: 4845726
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of pharmacokinetic drug interactions for the clinician].
    Kokot F; Kuska J
    Pol Arch Med Wewn; 1972; 48(1):91-100. PubMed ID: 4551132
    [No Abstract]   [Full Text] [Related]  

  • 19. Interference of drugs with chemical diagnostic tests.
    Drug Ther Bull; 1972 Sep; 10(18):69-72. PubMed ID: 5071263
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability under variable renal clearance conditions.
    Oie S; Jung D
    J Pharm Sci; 1979 Jan; 68(1):128-9. PubMed ID: 758455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.